NCT05599841

Brief Summary

Povidone iodine (PI) solution is an antimicrobial solution that can be used at hip and knee arthroplasty cases. It contains iodine that may be absorbed by the body. This study aims to investigate any absorption caused by PI solution.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

October 26, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2023

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

4.4 years

First QC Date

October 26, 2022

Last Update Submit

September 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urine iodine level

    Urine iodine concentration

    postoperative first day

Secondary Outcomes (1)

  • Thyroid hormone

    postoperative 14 days

Study Arms (2)

Povidone Iodine Solution

ACTIVE COMPARATOR

The group whom PI solution will be used at surgery

Procedure: PI solution

Saline Solution

PLACEBO COMPARATOR

The group whom only saline solution will be used at surgery

Procedure: Saline Solution

Interventions

PI solutionPROCEDURE

3,000 cc of \<2% concentrated povidone iodine solution will be used as irrigation solution at primary hip/knee arthroplasty. The PI solution was left in the joint for 3 minutes.

Povidone Iodine Solution

3,000 cc of 0.9% saline solution will be used as irrigation solution at primary hip/knee arthroplasty. The saline solution was left in the joint for 3

Saline Solution

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with hip/knee osteoarthritis who undergo primary arthroplasty

You may not qualify if:

  • Patients with abnormal thyroid function tests in the preoperative period, a history of the previous thyroid-related disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University Faculty of Medicine

Ankara, 06100, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Ertan MB, Basarir K, Kocaoglu H, Aydugan MY, Gungor E. Systemic iodine levels increase with povidone-iodine irrigation, but does this affect thyroid functions? A case-control study. J Orthop Surg Res. 2024 Oct 8;19(1):636. doi: 10.1186/s13018-024-04877-8.

MeSH Terms

Conditions

OsteoarthritisHyperthyroidism

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesThyroid DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Hakan Kocaoglu, MD

    Ankara University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hakan Kocaoglu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Assoc. Prof.

Study Record Dates

First Submitted

October 26, 2022

First Posted

October 31, 2022

Study Start

January 1, 2019

Primary Completion

May 31, 2023

Study Completion

September 16, 2023

Last Updated

September 21, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations